Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA dedicated Locations section has been added, listing New York and Texas sites, while the old 'New York Locations' and 'Texas Locations' labels were removed.SummaryDifference0.3%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedPublication section text updated to indicate PubMed publications are auto-filled and may not relate to the study. The page revision note was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page no longer displays the government funding lapse notice. The removal reduces a general status banner and does not alter the study details, eligibility criteria, or participating locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedNo significant changes detected in the study record; core details such as the title, purpose, interventions, and eligibility remain the same.SummaryDifference0.4%

- Check95 days agoChange DetectedUpdated operating-status notice and metadata: new warning about funding lapse and current status, plus a new 2025-10-01 timestamp and revision v3.2.0, replacing the previous 2025-05-07/08 references and revision v3.1.0.SummaryDifference3%

- Check102 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.